Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Free Report) Director Richard W. Mott acquired 12,100 shares of the company’s stock in a transaction on Wednesday, May 22nd. The shares were acquired at an average cost of $4.99 per share, for a total transaction of $60,379.00. Following the completion of the acquisition, the director now owns […]